Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.
Rapoport
Aaron P
AP
University of Maryland, Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, USA.
Aqui
Nicole A
NA
Stadtmauer
Edward A
EA
Vogl
Dan T
DT
Fang
Hong-Bin
HB
Cai
Ling
L
Janofsky
Stephen
S
Chew
Anne
A
Storek
Jan
J
Akpek
Gorgun
G
Badros
Ashraf
A
Yanovich
Saul
S
Tan
Ming T
MT
Veloso
Elizabeth
E
Pasetti
Marcela F
MF
Cross
Alan
A
Philip
Sunita
S
Murphy
Heather
H
Bhagat
Rita
R
Zheng
Zhaohui
Z
Milliron
Todd
T
Cotte
Julio
J
Cannon
Andrea
A
Levine
Bruce L
BL
Vonderheide
Robert H
RH
June
Carl H
CH
D000328:Adult; D000368:Aged; D000595:Amino Acid Sequence; D000951:Antigens, Neoplasm / Q000276:immunology; D003131:Combined Modality Therapy; D005076:Exanthema / Q000209:etiology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods*; D016219:Immunotherapy, Adoptive; D051034:Inhibitor of Apoptosis Proteins; D053208:Kaplan-Meier Estimate; D008297:Male; D008869:Microtubule-Associated Proteins / Q000737:chemistry / Q000276:immunology; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D009325:Nausea / Q000209:etiology; D010446:Peptide Fragments / Q000276:immunology*; D000077022:Survivin; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation; D019098:Telomerase / Q000737:chemistry / Q000276:immunology; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D014611:Vaccination / Q000009:adverse effects / Q000379:methods*; D014839:Vomiting / Q000209:etiology
D000951:Antigens, Neoplasm; C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D010446:Peptide Fragments; D000077022:Survivin; C509186:TERT protein, human; D019098:Telomerase